Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In continuation of our letter dated September 05, 2019, we enclose copies of the advertisements published on September 06, 2019, in Business Standard (English) and Business Standard [Hindi] with respect to: 1. Completion of despatch of Annual Reports along with Notices of AGM for the FY 2018-19; 2. Book Closure information; and 3. E-voting information relating to the AGM. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Book Closure For AGM (Cut-Off Date For E-Voting)
Pursuant to Section 91 of the Companies Act, 2013, the Register of Members and Share Transfer Books of the Company shall remain closed from Tuesday, September 24, 2019 to Monday, September 30, 2019 (both days inclusive) for the purpose of AGM and determining the eligibility for the payment of dividend @ 5% on fully paid up equity Share of Rs. 5/- each of the Company, subject to approval of shareholders in the ensuing AGM. The remote e-voting period will commences from Friday, 27th Day of September, 2019 (9:00 am) and ends on Sunday, 29th Day of September, 2019 (5:00 pm). During this period members' of the Company, holding shares either in physical form or in dematerialized form, as on the cut-off date of September 23, 2019, may cast their vote by remote e-voting. The remote e-voting module shall be disabled by NSDL for voting thereafter. Once the vote on a resolution is cast by the member, the member shall not be allowed to change it subsequently. Jagsonpal Pharmaceuticals Ltd - 507789 - Reg. 34 (1) Annual Report
We wish to inform you that 40th Annual General Meeting ("AGM") of Jagsonpal Pharmaceuticals Limited is scheduled to be held on Monday, the 30th day of September, 2019 at 10:00 A.M. at Vanita Samaj, 13, Institutional Area, New Delhi - 110003 to transact businesses as set out in the Notice of AGM. Copy of Annual Report for Financial Year 2018-19 along with Notice of AGM of the Company is enclosed; Jagsonpal Pharmaceuticals Ltd - 507789 - Shareholder''s Meeting AGM On 30Th Day Of September, 2019
NOTICE is hereby given that the 40th Annual General Meeting of the members of JAGSONPAL PHARMACEUTICALS LIMITED will be held on Monday,the 30th day of September, 2019 at 10.00 A.M. at Vanita Samaj, 13, Institutional Area, New Delhi - 110003 to transact the business as stipulated in the notice of the Annual General Meeting. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - SUBMISSION OF STANDALONE UN-AUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT FOR THE QUARTER ENDED 30TH JUNE, 2019.
SUBMISSION OF STANDALONE UN-AUDITED FINANCIAL RESULTS ALONG WITH LIMITED REVIEW REPORT FOR THE QUARTER ENDED 30TH JUNE, 2019. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Outcome of Board Meeting
OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON AUGUST 13TH, 2019. Jagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June, 2019.
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that Meeting of Board of Directors of the Company will be held on Tuesday, the 13th Day of August, 2019 at its registered office at 12:00 Noon, inter-alia, to consider and approve the following business: 1. To consider and approve the Un-Audited Financial Results of the Company for the quarter ended 30th June, 2019; 2. To consider and take note of Limited Review Report of Statutory Auditor on Un-Audited Financial Results of the Company for the quarter ended 30th June, 2019; 3. To consider & approve other agenda items as placed before the Board. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with Regulation 74 (5) of SEBl (Depositories and Participants) Regulations, 2018 we are forwarding herewith a copy of the Certificate received from M/s MCS Share Transfer Agent Limited, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th June, 2019. This is for your information & record. JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Shareholding for the Period Ended June 30, 2019
Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here JAGSONPAL PHARMACEUTICALS LTD. - 507789 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- R K KAPOORDesignation :- Company Secretary and Compliance Officer